A disruption in the transmission of insulin signaling, recognized as insulin resistance, is the main pathological process leading to T2DM, and is also an underlying pathology of other disorders included under the spectrum of “metabolic syndrome”. The gene discussed is INS; the disease is Insulin resistance.